Executive Summary
The dispute originated from a trade mark infringement suit where the plaintiff's case was dismissed for default. The plaintiff sought review, which the trial judge allowed. The defendant appealed this decision to the High Court. The court ultimately held that an appeal against a review order granted on grounds outside the scope of Order 47 is incompetent.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Andhra HC (Pre-Telangana). Understanding the court's reasoning in Mohd. Abdul Kereem vs M. Agaiah is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
K.L. ChaturvedivsState Of Madhya Pradesh And Ors.
The petitioner challenged the constitutionality of the Drugs Act, 1940, arguing that the amendment requiring mandatory disclosure of the true formula or ingredient list for his proprietary medicine 'Germs Killer' would expose his trade secret. The court upheld the amended provisions, finding them reasonable and necessary for public health and safety.
E. R. Squibb And Sons, LlcvsZydus Lifesciences Limited
The plaintiffs are seeking a permanent injunction against the defendant for infringing their patent related to the pharmaceutical product NIVOLUMAB, marketed as OPDYTA in India. The defendant is attempting to process a biosimilar version of the plaintiff's drug.
Gruner AgvsGuangxi Ramway Technology Co. Ltd.
The plaintiff filed a suit seeking permanent injunctions and damages against the defendants for alleged patent infringement. The court registered the plaint as a suit, issued summons, and set timelines for filing written statements and replication. Various interim applications regarding stay, additional documents, and directions to Customs were also addressed.
Novo Nordisk A/SvsDr Reddys Laboratories Limited & Anr.
Novo Nordisk A/S appealed an order where a Single Judge found infringement and granted limited relief to Dr Reddys Laboratories Limited. The appeal centers on whether the suit patent (IN 2626971) is vulnerable to invalidity under Section 64 of the Patents Act, given that the learned judge found the claim obvious from prior art.
Msn Laboratories Pvt. LtdvsThe Controller Of Patents & Anr.
The petitioner sought orders regarding the maintainability and survival of a revocation petition under Section 64 of the Patents Act, 1970. The court noted that the issue had been addressed by a Division Bench judgment in another appeal (Boehringer Ingelheim Pharma GMBH vs. The Controller of Patents & Anr).
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.